The Longevity Investor’s Case for Sauna: 40% Mortality Reduction and a $900M Market
By Arlene Scott
Senior Wellness Correspondent & Hospitality Consultant
- Published
- Reading time
- 8 min
SaunaNews is published by SaunaShare, Inc., which also runs SaunaShare.com and SaunaMarketplace.com, where we sell many of the products we write about. Assume that experience shapes what we cover and what we don't. Who owns SaunaNews · The ownership announcement
Finnish longitudinal data showing a 40% reduction in all-cause mortality for frequent sauna users, combined with a sauna equipment market approaching $1 billion, makes the investment case.
In this story2 sections
Longevity-focused venture capital hit $8.5 billion in 2024 according to Longevity.Technology’s annual investment report. Within that broad category, consumer-facing wellness products and services with clinical evidence are among the most actively funded. Sauna, though rarely discussed in the same breath as senolytics or NAD+ therapies, may be one of the category’s most interesting investment themes.
The evidence base
Sauna’s clinical evidence base is unusually strong for a consumer wellness product. The Kuopio Ischemic Heart Disease Risk Factor Study (KIHD), a 20+ year Finnish longitudinal study of approximately 2,300 middle-aged men published in JAMA Internal Medicine in 2015, found that frequent sauna use (4-7 sessions per week) was associated with a 40% reduction in all-cause mortality compared to once-weekly use. These findings have been replicated and extended by subsequent studies from the same research group.
For longevity-focused investors, this data is significant. Few consumer-facing interventions can point to large-scale, long-duration epidemiological evidence of this quality. Research on the mental health and social benefits of communal sauna use has since added another dimension to the evidence base.
Harvia CEO Matias Järnefelt has made the case for the category’s resilience to public market investors on more than one earnings call.
“The story resonates extremely well, almost no matter what the economic times are.” Matias Järnefelt, CEO, Harvia Plc, Q3 2025 earnings call, 6 November 2025
He has made the point again since: “I think it really tells a story that sauna is a strong trend that even defies the kind of environment outside the sauna market,” Järnefelt told analysts on the Q4 2025 earnings call on 12 February 2026. For a longevity thesis, that kind of macro insulation is what separates a durable category from a fitness fad.
The market opportunity
What makes sauna attractive from an investment perspective is the convergence of several favorable dynamics: strong and growing consumer demand, multiple scalable business models (manufacturing, retail, venues, digital), defensible brand-building opportunities, and a long runway for category expansion.
Where capital is flowing
Investment activity in sauna-adjacent companies has accelerated. Plunge, the cold plunge brand, bootstrapped its way to over $100 million in annual revenue by 2024 and has begun exploring outside capital. Commercial sauna venue operators are seeing interest from hospitality-focused PE firms. On the supplier side, Kohler’s deal to buy KLAFS, signed in December 2023, signaled that strategics see long-term value in the thermal wellness equipment space. Public-market investors can already buy a pure-play sauna listing through Harvia on Nasdaq Helsinki.
The sauna industry sits at the intersection of health science, consumer behavior, and scalable business models, a positioning that works well in a longevity investment environment still searching for opportunities with proven demand.
